Effects of Lorazepam during pregnancy and breast feeding

Lorazepam during pregnancy and lactation, Lorazepam category by FDA, its use during pregnancy and lactation its teratogenic effects are described.

Small amount of drug excrete into breast milk, if required low dose should be prescribed.

Lorazepam  during pregnancy and lactation
Pregnancy	Category D      ( by FDA ) Category C      ( AU TGA )
	Lorazepam drug crosses the placenta during pregnancy, not recommended  during pregnancy, Teratogenicity - congenital malformations, risk for withdrawal symptoms, neonatal flaccidity, respiratory and feeding difficulties, and hypothermia in children born to mothers who have been taking benzodiazepines late in pregnancy
Breast feeding	Lorazepam excretes in milk in small amount. Effect on nursing infants is unknown, chronic use associated with lethargic and to lose weight.